• LAST PRICE
    38.9700
  • TODAY'S CHANGE (%)
    Trending Down-1.0800 (-2.6966%)
  • Bid / Lots
    38.7100/ 1
  • Ask / Lots
    49.0000/ 1
  • Open / Previous Close
    39.8800 / 40.0500
  • Day Range
    Low 38.7400
    High 40.8750
  • 52 Week Range
    Low 12.6000
    High 67.2100
  • Volume
    354,480
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 40.05
TimeVolumePRAX
09:32 ET245139.64
09:34 ET218040.66
09:36 ET34640.22
09:39 ET10040.26
09:48 ET13040.3
09:52 ET80040.48
09:56 ET151440
09:57 ET10039.8
09:59 ET145639.98
10:01 ET332639.6
10:06 ET32939.52
10:10 ET36639.52
10:12 ET366939.745
10:14 ET70039.86
10:15 ET10039.79
10:17 ET21439.805
10:24 ET129440
10:26 ET30040.025
10:28 ET195640.39
10:32 ET18940.243
10:33 ET20040.265
10:35 ET12940.28
10:42 ET12840.31
10:46 ET40040.4
10:48 ET70040.845
10:50 ET155640.53
10:55 ET20040.38
10:57 ET171640.335
11:00 ET20040.36
11:04 ET16240.21
11:06 ET20039.87
11:09 ET10039.65
11:11 ET10039.59
11:15 ET10039.61
11:18 ET10039.785
11:20 ET10039.805
11:27 ET12239.645
11:31 ET70039.77
11:36 ET60039.72
11:40 ET10039.72
11:42 ET10039.705
11:44 ET40039.55
11:47 ET10039.44
11:54 ET10039.19
11:58 ET20239.27
12:00 ET80039.315
12:02 ET42439.48
12:03 ET30039.4
12:05 ET15080039.25
12:07 ET114439.171
12:09 ET10039.205
12:12 ET120039.63
12:14 ET10039.62
12:18 ET522939.2
12:21 ET50039.125
12:23 ET20039.105
12:25 ET40038.955
12:27 ET171138.995
12:30 ET60038.93
12:32 ET10038.85
12:36 ET78138.805
12:38 ET99339.094
12:39 ET20039.07
12:45 ET10039.075
12:52 ET200039.47
12:57 ET10039.435
01:03 ET10039.46
01:10 ET192039.73
01:14 ET30039.96
01:21 ET10039.98
01:26 ET10039.98
01:28 ET50039.81
01:30 ET20039.7
01:37 ET10039.74
01:39 ET10039.715
01:46 ET10039.38
01:48 ET60039.41
01:50 ET10039.5
01:51 ET40039.59
01:53 ET21639.62
01:57 ET10039.64
02:00 ET10039.645
02:02 ET48839.66
02:04 ET70039.66
02:06 ET10039.66
02:09 ET10039.665
02:11 ET17039.665
02:15 ET309939.525
02:22 ET50039.26
02:24 ET87539
02:27 ET20038.9
02:31 ET11138.93
02:33 ET10038.86
02:36 ET148938.95
02:38 ET20038.89
02:40 ET30039.095
02:44 ET200039.05
02:45 ET280039.58
02:47 ET37439.65
02:49 ET183839.43
02:54 ET30039.4
02:56 ET40039.32
02:58 ET10039.295
03:00 ET357539.39
03:02 ET220439.56
03:03 ET50039.605
03:05 ET274539.315
03:07 ET230039.51
03:09 ET30039.41
03:12 ET10039.45
03:14 ET10039.445
03:16 ET40039.32
03:20 ET108039.26
03:21 ET167039.37
03:23 ET10039.41
03:25 ET10039.3789
03:27 ET50039.4
03:30 ET20039.37
03:32 ET72039.375
03:34 ET51539.44
03:36 ET40739.46
03:38 ET111939.5
03:39 ET160739.61
03:41 ET10039.58
03:43 ET100039.44
03:45 ET90039.69
03:48 ET30039.5
03:50 ET50039.53
03:52 ET60039.56
03:54 ET84839.48
03:56 ET145339.16
03:57 ET150038.99
03:59 ET373138.97
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesPRAX
Praxis Precision Medicines Inc
666.7M
-2.4x
---
United StatesPHAT
Phathom Pharmaceuticals Inc
664.4M
-2.6x
---
United StatesLXRX
Lexicon Pharmaceuticals Inc
657.8M
-2.2x
---
United StatesCATX
Perspective Therapeutics Inc
683.1M
-6.6x
---
United StatesSSII
SS Innovations International Inc
683.0M
-29.2x
---
United StatesOLMA
Olema Pharmaceuticals Inc
691.3M
-6.1x
---
As of 2024-06-16

Company Information

Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company. It is focused on translating insights from genetic epilepsies into the development of therapies for central nervous system disorders characterized by neuronal excitation-inhibition imbalance. It is applying genetic insights to the discovery and development of therapies for neurological disorders through two platforms, using its understanding of shared biological targets and circuits in the brain. Its platform includes Cerebrum, a small molecule platform, which utilizes deep understanding of neuronal excitability and neuronal networks and applies a series of computational and experimental tools to develop orally available precision therapies, and Solidus, is an antisense oligonucleotide platform, is an efficient, targeted precision medicine discovery and development engine anchored on a proprietary, computational methodology. Its product candidates include ulixacaltamide, PRAX-562, PRAX-628 and elsunersen.

Contact Information

Headquarters
99 High Street, 30th FloorBOSTON, MA, United States 02110
Phone
617-300-8460
Fax
302-655-5049

Executives

Independent Chairman of the Board
Dean Mitchell
President, Chief Executive Officer, Director
Marcio Souza
Chief Financial Officer
Timothy Kelly
General Counsel, Corporate Secretary
Alex Nemiroff
Independent Director
Jeffrey Chodakewitz

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$666.7M
Revenue (TTM)
$2.2M
Shares Outstanding
17.1M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
2.76
EPS
$-15.91
Book Value
$7.92
P/E Ratio
-2.4x
Price/Sales (TTM)
303.7
Price/Cash Flow (TTM)
---
Operating Margin
-5,930.21%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.